FY2024 EPS Forecast for Vivani Medical Decreased by Analyst

Vivani Medical, Inc. (NASDAQ:VANI) – Equities research analysts at HC Wainwright decreased their FY2024 earnings per share estimates for Vivani Medical in a note issued to investors on Thursday, March 13th. HC Wainwright analyst Y. Chen now forecasts that the company will earn ($0.43) per share for the year, down from their previous estimate of ($0.41). HC Wainwright has a “Buy” rating and a $4.00 price target on the stock. The consensus estimate for Vivani Medical’s current full-year earnings is ($0.41) per share. HC Wainwright also issued estimates for Vivani Medical’s Q1 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.09) EPS, Q4 2025 earnings at ($0.09) EPS and FY2025 earnings at ($0.39) EPS.

Vivani Medical Stock Up 0.9 %

Shares of Vivani Medical stock opened at $1.10 on Monday. The stock has a market cap of $65.16 million, a P/E ratio of -2.44 and a beta of 3.20. Vivani Medical has a 12-month low of $1.03 and a 12-month high of $2.22. The business’s 50 day moving average is $1.16 and its 200-day moving average is $1.22.

Institutional Trading of Vivani Medical

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wealthedge Investment Advisors LLC bought a new position in shares of Vivani Medical in the 4th quarter valued at about $43,000. Jane Street Group LLC acquired a new stake in Vivani Medical in the 4th quarter valued at about $66,000. Northern Trust Corp grew its holdings in Vivani Medical by 19.1% during the fourth quarter. Northern Trust Corp now owns 71,915 shares of the company’s stock worth $83,000 after purchasing an additional 11,540 shares during the period. Finally, Geode Capital Management LLC grew its holdings in Vivani Medical by 4.6% during the third quarter. Geode Capital Management LLC now owns 342,891 shares of the company’s stock worth $401,000 after purchasing an additional 15,008 shares during the period. 6.78% of the stock is owned by institutional investors.

Vivani Medical Company Profile

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.